Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
NLNK > SEC Filings for NLNK > Form 8-K on 2-Jun-2014All Recent SEC Filings

Show all filings for NEWLINK GENETICS CORP

Form 8-K for NEWLINK GENETICS CORP


2-Jun-2014

Other Events


Item 8.01. Other Events.

On June 2, 2014, NewLink Genetics (NASDAQ:NLNK) announced additional data with its drug candidate algenpantucel-L that is currently under development for multiple indications in pancreatic cancer.

The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

On June 2, 2014, NewLink Genetics (NASDAQ:NLNK) announced continuing progress with its IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor program at the American Society for Clinical Oncology (ASCO) 2014 annual meeting.

The press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.


  Add NLNK to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NLNK - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.